Day: February 5, 2025

Appointments of Mohamed Kallala and Philippe Setbon to the Executive Management Committee of BPCE Paris, February 5, 2025 Mohamed Kallala, Chief Executive Officer of Natixis, in charge of Corporate & Investment Banking, and Philippe Setbon, Deputy Chief Executive Officer of Natixis, in charge of Asset & Wealth Management, are joining the Executive Management Committee of BPCE, following their direct reporting to Nicolas Namias, CEO of BPCE, since January 1, 2025. The Executive Management Committee of BPCE now has a total of twelve members. Biography of Mohamed Kallala Mohamed Kallala started his career in 1993 as an ALM trader for BNP Paribas before being appointed Head of Mergers & Acquisitions at Crédit Agricole Indosuez in 1995. In 2000, he founded Global Equities Corporate Finance. In 2005, he joined Natixis and became...

Allowing for Use Close to Electrical Motors, the RAIK060 Is Slimmer and Lighter Than Magnetic-Based Encoders, With Higher Rotational Speed and Lower Latency Time MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new high precision position sensor built on inductive technology for industrial and AMS applications. Compared to solutions based on magnetic technology, the Vishay MCB RAIK060 absolute inductive kit encoder offers a smaller thickness of 5 mm, lighter weight of 15.5 g, higher rotational speeds to 10 000 rpm, and a lower latency time of ≤ 5 μs. In addition, the device isn’t sensitive to magnetic environments, allowing it to be used close to electrical motors. The position sensor released today is ideal for robotics, motor drives, and other demanding industrial applications...

EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal first quarter ended December 31, 2024, before market open on February 12, 2025. Management will host an investor conference call and webcast at 8:30 a.m. eastern time on Wednesday, February 12, 2025, to discuss the Company’s first quarter 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information: First Quarter and Fiscal 2025 Earnings Conference CallDate: Wednesday, February 12, 2025Time:...

February 5, 2025 Avance Gas Holding Ltd (the “Company”) advises that a Special General Meeting (SGM) of the Shareholders of the Company was held on 5 February 2025 at 09:00 (local time), at Par-la-Ville Place, 4th Floor, 14 Par-la-Ville Road, Hamilton Bermuda (the “Meeting”).  At the Meeting, the shareholders resolved that the Company’s Share Premium account shall be reduced from US$446,358,298 to US$nil by the transfer of US$446,358,298 of the Share Premium account to the Company’s Contributed Surplus account with immediate effect. The Board of Directors Avance Gas Holding Ltd Hamilton, BermudaThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today provided notice (the “Notice”) to holders of its 7.00% Convertible Senior Notes due 2029 (the “Notes”), pursuant to the terms of the Indenture, dated as of March 12, 2024 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association (“U.S. Bank”), as trustee, governing the Notes that, in connection with the closing of the transaction contemplated by the Agreement and Plan of Merger, dated as of November 6, 2024 (the “Merger Agreement” and such transaction, the “Merger”),...

WINTER PARK, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) — Adia Nutrition Inc. (OTC Pink: ADIA), an innovator nutritional products and medical treatments, has announced that through collaboration with Adia’s accountant, Adia has appointed a PCAOB (Public Company Accounting Oversight Board) accounting firm to conduct a comprehensive third-party audit. This strategic move is part of Adia’s plan to uplist its shares from the OTC Pink Sheets to the OTCQB Venture Market, aiming to enhance visibility, attract a broader investor base, and reflect the company’s commitment to transparency and growth. “Having a fully running business model for the past year, we are now taking this significant step towards uplisting to OTCQB,” said Larry Powalisz, CEO of Adia Nutrition. “This audit will not only validate our financial...